CABALETTA BIO INC (CABA:NASDAQ)
$3.13 -0.04 (-1.2618%)
Analysed CABALETTA BIO INC (CABA:NASDAQ) News Sources
This Biotech Stock Could Deliver 350% Returns in 12 Months
27-03-2026
yahoo.com
Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
23-03-2026
yahoo.com
Cabaletta Bio Highlights Pivotal Myositis Trial, No-Preconditioning CAR-T Push at TD Cowen Conference
07-03-2026
marketbeat.com
Cabaletta Bio (CABA) Upgraded to Buy: Here's What You Should Know
06-03-2026
yahoo.com
Are Medical Stocks Lagging Biodesix (BDSX) This Year?
03-03-2026
yahoo.com
Cabaletta Bio to Participate in the TD Cowen 46th Annual Health Care Conference
24-02-2026
yahoo.com
Here’s Why Jacob Funds Established a Position in Cabaletta Bio (CABA)
18-02-2026
yahoo.com
Cabaletta Bio Kicks Off Pivotal Myositis Trial, Touts Automated CAR-T Manufacturing Path to 2027 BLA
13-02-2026
marketbeat.com
Is Anavex Life Sciences (AVXL) Stock Outpacing Its Medical Peers This Year?
12-02-2026
yahoo.com
Cabaletta Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
05-02-2026
yahoo.com
What is the current price of CABALETTA BIO INC (CABA:NASDAQ)?
The current price of CABALETTA BIO INC (CABA:NASDAQ) is $3.13.
CABALETTA BIO INC (CABA:NASDAQ) absolute price change since previous trading day?
The absolute price change of CABALETTA BIO INC (CABA:NASDAQ) since the previous trading day is $-0.04.
CABALETTA BIO INC (CABA:NASDAQ) percentage price change since previous trading day?
The percentage price change of CABALETTA BIO INC (CABA:NASDAQ) since the previous trading day is -1.2618%.
What is the most recent average sentiment score for CABALETTA BIO INC (CABA:NASDAQ)?
The most recent average sentiment score for CABALETTA BIO INC (CABA:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for CABALETTA BIO INC (CABA:NASDAQ)?
The most recent sentiment for CABALETTA BIO INC (CABA:NASDAQ) is .
SEC-8K** Filing Available For CABALETTA BIO INC (CABA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.